Cargando…
Genetics dictating therapeutic decisions in pediatric pulmonary hypertension? A case report suggesting we are getting closer
Despite therapeutic advances over the past decades, pulmonary arterial hypertension (PAH) and related pulmonary vascular diseases continue to cause significant morbidity and mortality in neonates, infants, and children. Unfortunately, an adequate understanding of underlying biology is lacking. There...
Autores principales: | Stevens, Leah, Colglazier, Elizabeth, Parker, Claire, Amin, Elena K., Nawaytou, Hythem, Teitel, David, Reddy, Vadiyala M., Welch, Carrie L., Chung, Wendy K., Fineman, Jeffrey R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052973/ https://www.ncbi.nlm.nih.gov/pubmed/35506084 http://dx.doi.org/10.1002/pul2.12033 |
Ejemplares similares
-
Pushing the envelope: a treat and repair strategy for patients with advanced pulmonary hypertension associated with congenital heart disease
por: Kameny, Rebecca Johnson, et al.
Publicado: (2017) -
Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension
por: Colglazier, Elizabeth, et al.
Publicado: (2022) -
Persistence of persistent pulmonary hypertension of the newborn: A case of de novo TBX4 variant
por: Tsoi, Stephanie M., et al.
Publicado: (2022) -
Postablation Right Atrial Dissection in Ebstein's Anomaly
por: Hassan, Fatemat, et al.
Publicado: (2017) -
Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case series
por: Colglazier, Elizabeth, et al.
Publicado: (2023)